Chlamydia Screening in Women
This HEDIS Measure
Assesses women 16–24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.
Chlamydia is the most commonly reported bacterial sexually transmitted disease in the United States, occurring most often among adolescent and young adult females.1,2 Untreated chlamydia infections can lead to serious and irreversible complications, including pelvic inflammatory disease (PID), infertility and increased risk of becoming infected with HIV.1 Screening is important, as approximately 75 percent of chlamydia infections in women and 95 percent of infections in men are asymptomatic, resulting in delayed medical care and treatment.3
- Centers for Disease Control and Prevention (CDC). 2014. “Sexually Transmitted Diseases: Chlamydia—CDC Fact Sheet.” http://www.cdc.gov/std/chlamydia/STDFact-chlamydia-detailed.htm
- National Chlamydia Coalition. 2010. “Research Briefs: Developments in STD Screening: Chlamydia Testing.” 2010 Series, No. 1.
- Meyers, D.S., H. Halvorson, S. Luckhaupt. 2007. “Screening for Chlamydial Infection: An Evidence Update for the U.S. Preventive Services Task Force.” Ann Intern Med 147(2):135–42.